Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Extrasystolic Potentiation as a Predictor of Ventricular Arrhythmias

NCT03631303 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.

NCT NCT03631303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03631303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Extrasystolic Potentiation as a Predictor of Ventricular Arrhythmias
Lead sponsor
Amsterdam UMC, location VUmc
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2018
Completion date
March 1, 2020
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-extrasystolic potentiation (pesp), ventricular tachycardia